Independent Lab Finds Novaerus Plasma Kills 99.9% Flu Virus on Contact

Novaerus Plasma-Based NV900 Eradicates Airborne Virus

Raleigh, N.C. – October 11, 2016  Aerosol Research and Engineering Lab conducted an independent study with the Novaerus NV900 and found it effective in killing the airborne MS2 virus, a surrogate for influenza. “In a matter of hours, the air showed a 4.4 log reduction, which translates to a 99.99% reduction of the virus in the air,” says Felipe Soberon, Chief Technology Officer of Novaerus.

He continues, “This finding is significant in support of plasma-based air purification technology as a safe and effective approach to infection control measures.” Facilities from healthcare to hotels and schools are plagued during the flu season. Flu viruses, however, are usually transmitted through droplets coughed or sneezed into the air. Alone, traditional hand washing and cleaning methods are not enough to prevent and contain outbreaks. During the flu season, it is critical to destroy viruses in the air before they are inhaled or land on surfaces. This provides a comprehensive infection defence system for high traffic indoor facilities. Strong enough to destroy bacteria, viruses, mould, spores and allergens. Its safe design runs 24/7 to annihilate airborne pathogens. Novaerus is committed to the highest indoor air quality.

Developed in 2008, Novaerus technology generates what is called a Dielectric Barrier Discharge plasma or DBD. When microorganisms in the air, including toxins, come into contact with the DBD plasma, they are eliminated. Novaerus enables facilities to reduce negative financial impacts associated with viral outbreaks, such as staff absenteeism. To learn more about Novaerus and its air quality control solutions, visit www.novaerus.com.

Novaerus Encourages Healthcare Professionals to Pledge Commitment to Clean Air

New pledge lays out Novaerus’ fight against invisible threats with innovative technology

Raleigh, N.C. – August 8, 2016 – Novaerus today introduces a call to healthcare, education and hospitality professionals to pledge their commitment to clean air through total annihilation of invisible threats.   “The introduction of plasma-based solutions for airborne pathogen control is a 21st-century approach to a major public and personal health issue,” said Terry Sullivan, MD of NTST consulting. “The spread of infectious diseases, especially those with high levels of antibiotic resistance, is a serious threat to patients within healthcare facilities.”   The pledge, centred on total annihilation of invisible threats, seeks to defend what matters most – the air we breathe, the people we love and those who care for our loved ones.

Novaerus will be among exhibitors at the Florida Health Care Association annual trade show and conference on August 8 in Orlando, Fla. to launch the campaign and educate the industry on the importance of clean air. Novaerus, a company that produces infection prevention technology, uses state of the art plasma coils to safely remove 99.9% of harmful pathogens in the air.

Developed in 2008, Novaerus technology generates what is called a Dielectric Barrier Discharge (DBD) plasma. When microorganisms in the air, including toxins, come into contact with the DBD plasma, they are eliminated. The technology is a green solution that saves 30% on energy costs each year.  The technology Novaerus uses is a completely different approach to air quality control, and it works. The company has proven technology in high-population spaces where germs commonly pose serious risks, such as hospitals, long-term health care facilities and hotels. In the 30 countries where Novaerus products are used, studies to date show that Novaerus technology effectively reduces the bio-burden in the air.   To learn more about Novaerus and its air quality control solutions, visit www.novaerus.com.